Literature DB >> 2365146

A mitochondrial myopathy in an infant with lactic acidosis.

V Griebel1, I Krägeloh-Mann, W Ruitenbeek, J M Trijbels, W Paulus.   

Abstract

We describe a girl with mitochondrial myopathy, who presented with general muscle weakness, muscle hypotonia and motor retardation. The level of blood lactate and pyruvate was consistently increased. Enzymatic studies showed impairment of NADH-dehydrogenase activity (complex I of the respiratory chain) in skeletal muscle. Electron-microscopy of a muscle biopsy showed abnormalities of a mitochondrial myopathy. The girl, now aged 30 months, has been treated with riboflavine (vitamin B2) since the age of 14 months, and lactate and pyruvate levels have decreased to normal. The patient still shows mild muscle hypotonia and weakness, but good motor progress and normal cognitive development.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2365146     DOI: 10.1111/j.1469-8749.1990.tb16979.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  6 in total

Review 1.  The treatment of congenital lactic acidoses.

Authors:  A A Morris; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

2.  Adaptive regulation of riboflavin transport in heart: effect of dietary riboflavin deficiency in cardiovascular pathogenesis.

Authors:  Tamilarasan Udhayabanu; Sellamuthu Karthi; Ayyavu Mahesh; Perumal Varalakshmi; Andreea Manole; Henry Houlden; Balasubramaniem Ashokkumar
Journal:  Mol Cell Biochem       Date:  2017-08-23       Impact factor: 3.396

Review 3.  Multicystic encephalomalacia in term infants.

Authors:  G Frigieri; B Guidi; S Costa Zaccarelli; C Rossi; G Muratori; F Ferrari; G B Cavazzuti
Journal:  Childs Nerv Syst       Date:  1996-12       Impact factor: 1.475

4.  49,XXXXY: a distinct phenotype. Three new cases and review.

Authors:  J Peet; D D Weaver; G H Vance
Journal:  J Med Genet       Date:  1998-05       Impact factor: 6.318

Review 5.  The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease.

Authors:  Elizabeth A Mazzio; Fran Close; Karam F A Soliman
Journal:  Int J Mol Sci       Date:  2011-01-17       Impact factor: 5.923

Review 6.  Riboflavin Responsive Mitochondrial Dysfunction in Neurodegenerative Diseases.

Authors:  Tamilarasan Udhayabanu; Andreea Manole; Mohan Rajeshwari; Perumal Varalakshmi; Henry Houlden; Balasubramaniem Ashokkumar
Journal:  J Clin Med       Date:  2017-05-05       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.